Pca Prostata-Analyse

Intelligent use of PSA in 2012 / How to best screen for prostate cancer? J Hugosson, Göteborg

Prostata-Behandlungsmethoden NAR

Study record managers: refer to the Data Element Definitions pca Prostata-Analyse submitting registration or results information. Compare locoregional control, disease-free survival, and overall survival in patients with carcinoma of the prostate who are considered at high risk of relapse and receive long-term adjuvant zoladex ZDX vs.

Compare sexual function in patients treated with these two regimens. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study pca Prostata-Analyse staff using the contacts provided below. For general information, Learn About Clinical Studies.

Hide glossary Glossary Study pca Prostata-Analyse managers: refer to the Data Element Definitions if submitting registration or results information. Search for terms x. Save this study. Warning You have reached the maximum number of saved studies Goserelin, Flutamine, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators.

Listing a study does not mean it has pca Prostata-Analyse evaluated by the U. Federal Government. Read our disclaimer for details. Last Update Posted : January 28, pca Prostata-Analyse Study Description.

Drug Information available for: Goserelin. FDA Pca Prostata-Analyse. Arms and Interventions. Outcome Measures. Eligibility Criteria. Information from the National Library of Medicine Choosing to participate in a study is an important personal decision. Contacts and Locations. Information from the National Library of Medicine To learn more about this study, you or your doctor may pca Prostata-Analyse the study research staff using the contact information provided by the sponsor. Please refer pca Prostata-Analyse this study by its ClinicalTrials.

Pca Prostata-Analyse table for investigator information Study Chair: Gerald E. More Information. MDM2 and Ki predict for distant metastasis and pca Prostata-Analyse in men treated with radiotherapy pca Prostata-Analyse androgen deprivation for prostate cancer: RTOG J Clin Oncol. Epub May The importance of protein kinase A in prostate cancer: relationship to patient outcome in Radiation Therapy Pca Prostata-Analyse Group trial Clin Cancer Res.

Epub Aug Potential surrogate endpoints for pca Prostata-Analyse cancer survival: analysis of a phase III randomized trial. J Natl Cancer Pca Prostata-Analyse.

Epub Feb Cardiovascular mortality and duration of androgen deprivation for locally advanced prostate cancer: analysis of RTOG Eur Urol. Epub Jan Ten-year follow-up of radiation therapy oncology group protocol a phase III trial pca Prostata-Analyse the duration of elective androgen deprivation in locally advanced prostate cancer. Epub Apr Diabetes and mortality in men with locally advanced prostate cancer: RTOG Prognostic value of p16 in locally advanced prostate cancer: a study based on Radiation Therapy Oncology Group Protocol Lancet Oncol.

Epub Sep Bcl-2 and Bax expression predict prostate cancer outcome in men treated with androgen deprivation and radiotherapy on radiation therapy oncology group protocol Long-term hormone therapy and radiation is cost-effective for patients with locally advanced prostate carcinoma.

Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: an analysis of Radiation Therapy Oncology Group Protocol Prognostic value of abnormal p53 expression in locally pca Prostata-Analyse prostate cancer treated with androgen deprivation and radiotherapy: a study based on RTOG Epub Aug 8.

Ki staining pca Prostata-Analyse a strong predictor of distant metastasis and mortality for men with prostate cancer treated with radiotherapy plus androgen deprivation: Radiation Therapy Oncology Group Trial Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction and radiotherapy in locally advanced carcinoma of the prostate: the Radiation Therapy Oncology Group Protocol Erratum in: J Clin Oncol.

Analysis of RTOG protocol Impact of marital status and race on outcomes of patients enrolled in Radiation Therapy Oncology Group prostate cancer trials.

Support Care Cancer. Epub Jul 1. Older age predicts decreased metastasis and prostate cancer-specific death for men treated with radiation therapy: meta-analysis of radiation therapy oncology group trials.

Epub Mar Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Pca Prostata-Analyse Group prostate clinical trials.

Baseline serum testosterone in men treated with androgen deprivation therapy and radiotherapy for localized prostate pca Prostata-Analyse.

Epub Apr 8. Predictive models in external beam radiotherapy for clinically localized prostate pca Prostata-Analyse. Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies, and Epub Oct Whelan P. Editorial comment on: Cardiovascular mortality and duration of androgen deprivation for pca Prostata-Analyse advanced prostate cancer: analysis of RTOG A, National Library of Medicine U.

National Institutes of Health U. Department of Health and Human Services. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Prostate Cancer. Phase 3. Study Type :. Actual Study Completion Date :.